IL6 and diabetes mellitus: Firstly, the expression of critical pro-inflammatory factors such as interleukin-1β(IL-1β), IL-1, IL-6 and tumor necrosis factor-α (TNF-α) is increased in patients with DM (Turkmen, 2017).